Acciones Isodiol International Inc Other OTC
Acciones
CA46500L1013
Farmacéuticos
Ventas 2018 | 19,14 M 17,82 M | Ventas 2019 | 22,25 M 20,71 M | Capitalización | 49,96 M 46,51 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -36 M -33,51 M | Resultado Neto 2019 | -126 M -117 M | VE / Ventas 2018 | 12,6 x |
Posición de caja neta 2018 | 15,55 M 14,48 M | Deuda neta 2019 | 5,22 M 4,86 M | VE / Ventas 2019 | 2,48 x |
P/E ratio 2018 |
-4,94
x | P/E ratio 2019 |
-0,37
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+41,81 % | 6201,11 M | |
-22,93 % | 4100,92 M | |
+9,84 % | 3413 M | |
-18,80 % | 2828,11 M | |
-10,82 % | 2286,94 M | |
+48,92 % | 1933,57 M | |
-7,03 % | 1521,55 M | |
+49,25 % | 1514,53 M | |
-15,60 % | 1493,95 M |